Terms: = Endocrine gland cancer AND BRAF, MGC126806, 673, ENSG00000157764, MGC138284, RAFB1, P15056, B-raf 1, BRAF1, B-raf1
3006 results:
1. Diagnostic value of FNAC combined with braf
Fu J; Yin X; Wang X; Xiao S; Wu X; Duan C; Yu W; Zhang G
Front Endocrinol (Lausanne); 2024; 15():1366724. PubMed ID: 38818506
[TBL] [Abstract] [Full Text] [Related]
2. Influence of maximum diameter on fine-needle aspiration biopsy outcomes in ACR TI-RADS 5 thyroid nodules.
Cao SL; Shi WY; Niu YR; Zhao ZL; Wei Y; Wu J; Peng LL; Li Y; Yu MA
Front Endocrinol (Lausanne); 2024; 15():1374888. PubMed ID: 38808118
[TBL] [Abstract] [Full Text] [Related]
3. Targeting miR-31 represses tumourigenesis and dedifferentiation of braf
Zhang P; Guan L; Sun W; Zhang Y; Du Y; Yuan S; Cao X; Yu Z; Jia Q; Zheng X; Meng Z; Li X; Zhao L
Clin Transl Med; 2024 May; 14(5):e1694. PubMed ID: 38797942
[TBL] [Abstract] [Full Text] [Related]
4. [Neurofibromatosis type 1 associated with pheochromocytoma: a case report with a brief review of the literature].
Lugovskaya AY; Britvin TA; Gurevich LE; Rog IS; Nefedova LN; Ilovayskaya IA
Probl Endokrinol (Mosk); 2023 Sep; 70(2):53-64. PubMed ID: 38796761
[TBL] [Abstract] [Full Text] [Related]
5. Targeting NG2 relieves the resistance of braf-mutant thyroid cancer cells to braf inhibitors.
Sui F; Wang G; Liu J; Yuan M; Chen P; Yao Y; Zhang S; Ji M; Hou P
Cell Mol Life Sci; 2024 May; 81(1):238. PubMed ID: 38795180
[TBL] [Abstract] [Full Text] [Related]
6. [The relationship between differentially expressed thyroid cancer genes and clinical characteristics in metastatic children and adolescents].
Pan YJ; Ju GD; Mu ZZ; Sun YQ; Sun D; Liang J; Lin YS
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1837-1843. PubMed ID: 38782752
[No Abstract] [Full Text] [Related]
7. Discriminating Interpatient Variabilities of RAS Gene Variants for Precision Detection of Thyroid cancer.
Fu G; Chazen RS; MacMillan C; Witterick IJ
JAMA Netw Open; 2024 May; 7(5):e2411919. PubMed ID: 38758552
[TBL] [Abstract] [Full Text] [Related]
8.
Prabhash K; Saldanha E; Patil V; Bal M; Reddy P S; Sanjeev A; Kumar R; Poojary D; Noronha V; Menon N; Mittal N; Trivedi V; Nambiar K; Mishra R; Tanwar N; Malhotra R; Pange P; Gupta V; Veldore VH; Chougule A; Chaturvedi P; Dutt A; Chandrani P
JCO Precis Oncol; 2024 May; 8():e2300622. PubMed ID: 38754058
[TBL] [Abstract] [Full Text] [Related]
9. [The clinicopathological features of adult thyroid tumors with DICER1 mutation].
Tang J; Huang JJ; Luo YL; Zhang LK; Wang QQ; Chen J; Liu ZY
Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1623-1627. PubMed ID: 38742350
[TBL] [Abstract] [Full Text] [Related]
10. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
[TBL] [Abstract] [Full Text] [Related]
11. Columnar Cell Thyroid Carcinoma: A Heterogeneous Entity Demonstrating Overlap Between Papillary Thyroid Carcinoma and Follicular Neoplasms.
Higgins KE; Sadow PM; Johnson DN; Wang P; Wanjari P; Cipriani NA
Head Neck Pathol; 2024 May; 18(1):39. PubMed ID: 38727854
[TBL] [Abstract] [Full Text] [Related]
12. [Molecular diagnostics enable targeted therapies for anaplastic and poorly differentiated thyroid cancer].
Altena R; Nilsson M; Bergman V; Dahlberg J; Christofer Juhlin C; Zedenius J
Lakartidningen; 2024 Feb; 121():. PubMed ID: 38712675
[TBL] [Abstract] [Full Text] [Related]
13. braf mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases.
Kalfert D; Ludvikova M; Pesta M; Hakala T; Dostalova L; Grundmannova H; Windrichova J; Houfkova K; Knizkova T; Ludvik J; Polivka J; Kholova I
Pathol Res Pract; 2024 Jun; 258():155319. PubMed ID: 38696857
[TBL] [Abstract] [Full Text] [Related]
14. Rathke's Cleft Cyst and Craniopharyngioma: A Continuum of the Same Spectrum? Insights from an Interesting Case and Previous Literature.
Sharma R; Meena R; Ganeshkumar A; Narwal A; Doddamani R; Singh M; Chandra SP
Neurol India; 2024 Mar; 72(2):403-407. PubMed ID: 38691485
[TBL] [Abstract] [Full Text] [Related]
15. Antitumor activity of extracellular signal-regulated kinases 1/2 inhibitor BVD-523 (ulixertinib) on thyroid cancer cells.
Chen Y; Xiao X; Hu G; Liu R; Xue J
J Cancer Res Ther; 2024 Apr; 20(2):570-577. PubMed ID: 38687926
[TBL] [Abstract] [Full Text] [Related]
16. Thyroid cancer and endocrine disruptive chemicals: a case-control study on per-fluoroalkyl substances and other persistent organic pollutants.
Cirello V; Lugaresi M; Moneta C; Dufour P; Manzo A; Carbone E; Colombo C; Fugazzola L; Charlier C; Pirard C
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38657654
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic value of high-frequency ultrasound combined with fine needle aspiration cytology and braf gene for papillary thyroid microcarcinoma.
Li C; Zhao X; Zhao J; Zhao J; An L; Wu G
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):187-191. PubMed ID: 38650135
[TBL] [Abstract] [Full Text] [Related]
18. Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers.
Syed AR; Gorana A; Nohr E; Yuan XK; Amin MASc P; Ghaznavi S; Lamb D; McIntyre J; Eszlinger M; Paschke R
Eur Thyroid J; 2024 Jun; 13(3):. PubMed ID: 38642578
[TBL] [Abstract] [Full Text] [Related]
19. Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring braf
Wang X; Cui X; Wang Y; Wang Q; Sun F; Liu Z
Toxicology; 2024 May; 504():153807. PubMed ID: 38641160
[TBL] [Abstract] [Full Text] [Related]
20. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
[Next]
